Security key
501147102
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Total 13F shares
- 19,309,579
- Total 13F value
- $1,350,723,574
- Share change
- +2,879,249
- Put/Call ratio
- 117%
- SEC-reported price per share
- $69.95
- Number of holders
- 135
- Value change
- +$209,084,528
- Number of buys
- 89
- Number of sells
- 43
- Shares outstanding
- 29,463,330
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
135
Top holders
10
KRYS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Krystal Biotech, Inc. SEC filings
Krystal Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501147102
Recent filing periods:
Ownership snapshot
Top reported holders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Redmile Group, LLC
Disclosed value leader
Redmile Group, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 6.7%
Showing 1-6 of 15 holder rows.
Quick read
Redmile Group, LLC leads the comparable SEC ownership view at 6.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Redmile Group, LLC's linked filing trail.
Comparable ownership
Top 5
Redmile Group, LLC
6.7%
FMR LLC
6.5%
BlackRock Finance, Inc.
5.2%
LORD, ABBETT & CO. LLC
3.6%
VANGUARD GROUP INC
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
Company
|
6.7%
|
$103,503,000
1,982,432 shares
|
— | 30 Sep 2021 |
| FMR LLC |
13F
Company
|
6.5%
|
$99,325,000
1,902,405 shares
|
— | 30 Sep 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
5.2%
|
$80,476,000
1,541,386 shares
|
— | 30 Sep 2021 |
| LORD, ABBETT & CO. LLC |
13F
Company
|
3.6%
|
$55,716,000
1,067,158 shares
|
— | 30 Sep 2021 |
| VANGUARD GROUP INC |
13F
Company
|
3%
|
$46,396,000
888,658 shares
|
— | 30 Sep 2021 |
| CREDIT SUISSE AG/ |
13F
Company
|
2.6%
|
$40,304,000
771,954 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
135
Shares
19,309,579
Rows available
135
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
112
Q4 2021 holders
135
Holder diff
23
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend